Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding scheduled to begin after Labor Day. The deal reshapes Michigan's banking landscape and creates the nation's ninth-largest bank.
As global leaders gather in Davos, a coalition of over 400 affluent individuals from 24 nations issues a stark demand: governments must impose higher taxes on the ultra-wealthy to tackle inequality.
A new Deloitte report urges enterprises to embed accountability and oversight from the start, arguing that governance is not a barrier but an accelerator for scaling autonomous AI systems.
A broad sell-off in risk assets, from equities to precious metals, has triggered over $2.5 billion in Bitcoin liquidations. Analysts point to shifting Federal Reserve expectations and AI trade anxieties as key drivers behind the latest crypto market tremor.
After a sharp January sell-off, Shopify's stock is hovering near a significant long-term trendline—a level that has preceded notable rallies in the past.
CNBC's Jim Cramer endorsed Carrier Global Corp. (NYSE:CARR) on his recent show, praising CEO Dave Gitlin's leadership and strategic acquisition. He recommended investors buy the stock for the long term, citing confidence in the company's positioning within the climate solutions sector.
CNBC's Jim Cramer reaffirmed his bullish stance on Palantir Technologies during a recent 'Mad Money' segment, placing the data analytics firm in the same league as established giants like ServiceNow and Salesforce.
CNBC's Jim Cramer reaffirms his bullish stance on NVIDIA, calling the chipmaker the dominant force in the rapidly evolving artificial intelligence landscape, while analysts debate the sustainability of its market position.
CNBC's Jim Cramer positions Alphabet as the potential 'only winner in AI,' suggesting its upcoming earnings may show it generating more revenue from AI than rival Meta Platforms.
CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
Despite modest nominal gains, real wages for U.S. workers are failing to keep pace with the cost of living, with a majority reporting financial strain as structural economic shifts and technological efficiencies redirect gains away from paychecks.
Personal finance icon Suze Orman echoes a timeless principle from Napoleon Hill's 'Think and Grow Rich': the battle for wealth is won or lost in the mind. Experts argue that self-doubt, not market conditions, is the primary barrier most people face.
The rapid adoption of algorithmic decision-making in UK banks has created a critical lag in oversight and accountability structures, leaving institutions exposed to risks that traditional governance models are ill-equipped to manage.
Despite its dominance and a recent surge to over 325 million subscribers, Netflix faces mounting criticism over pricing, content decisions, and user experience. An analysis of consumer feedback reveals the key frustrations testing viewer loyalty in an increasingly competitive streaming landscape.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
Six Flags Entertainment's shares have tumbled nearly 60% over the past year, trading far below industry peers. A deep dive into its valuation metrics reveals a significant discount, but questions remain about its path to recovery in a shifting leisure landscape.
BioNTech's stock faces pressure following a Leerink Partners downgrade, which tempered near-term optimism around its oncology pipeline after a recent rally. The move highlights investor reassessment of catalysts amid mixed long-term performance.
Despite both tech giants aggressively investing in AI, their stock prices are telling divergent stories. We examine the underlying fundamentals that make them resilient picks for any portfolio, regardless of short-term volatility.
Amid subscription fatigue and market fragmentation, the proposed union of Netflix and Warner Bros. Discovery is framed not as a threat to competition, but as a necessary consolidation to compete with tech giants and refocus value on consumers.
